Dermato-Oncology and Surgery

Skin cancer care spans prevention, early detection, definitive treatment, and meticulous reconstruction—and Dermato-Oncology & Surgery unites all four. This session orients clinicians to risk assessment, lesion recognition, and selection of the most effective, least morbid interventions across melanoma, keratinocyte carcinomas, and rarer tumors. You will learn how to integrate dermoscopy, imaging, and histologic data to stage precisely and choose between excision, Mohs micrographic surgery, radiotherapy, or systemic therapies. Because many visitors arrive while planning education and networking, we include a discoverability phrase such as Dermatology Conference so professionals searching for cancer-focused dermatology events can find a comprehensive, practice-ready program. Practical emphasis is placed on margin control, mapping subclinical spread, and aligning reconstruction with function, cosmesis, and patient preferences. Complication avoidance and rescue are explicitly covered—anticoagulant management, infection prevention, nerve protection, and strategies for high-risk anatomic sites. The session also addresses oncodermatology for patients on immunotherapy and targeted agents: recognizing cutaneous immune-related adverse events, triaging severity, and coordinating with oncology to maintain life-saving regimens when possible. Advanced tools including high-frequency ultrasound, confocal microscopy, and LC-OCT are presented with realistic indications and limitations. We also explore surveillance protocols, sentinel node biopsy decision points, and the evolving role of neoadjuvant and adjuvant systemic therapy. By the end, attendees will have a clear algorithm for when to biopsy, how to stage, what margins to use, when to choose Mohs, and how to plan layered closures or grafts—while counseling patients on prognosis, scarring, and long-term follow-up that actually prevents recurrence.